Breaking News
Get 50% Off 0
💎 Bargain Hunter: Undervalued stocks with massive upside potential
Get the list
Close

Briacell Therapeutics Corp (BCT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.84 -0.22    -20.75%
06/08 - Closed. Currency in CAD
Type:  Equity
Market:  Canada
  • Volume: 206,054
  • Bid/Ask: 0.84 / 1.03
  • Day's Range: 0.84 - 1.01
Briacell Therapeutics 0.84 -0.22 -20.75%

Briacell Therapeutics Corp Company Profile

 
Get an in-depth profile of Briacell Therapeutics Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

16

Equity Type

ORD

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Contact Information

Address Bellevue Centre Suite 300
235 -15th Street West Vancouver, V7T 2X1
Canada
Phone 604-921-1810
Fax 604-921-1898

Top Executives

Name Age Since Title
Charles Louis Wiseman 78 2014 Founder, Principal Research Advisor & Member of Scientific Advisory Board
William V. Williams 69 2016 CEO, President & Director
Jamieson Bondarenko 39 2019 Independent Chairman of the Board
Vaughn C. Embro-Pantalony 67 2019 Lead Independent Director
Martin E. Schmieg 62 2020 Independent Director
Douglas V. Faller - 2017 Member of Scientific Advisory Board
Brian W. Metcalf 78 2017 Member of Scientific Advisory Board
Thomas Kieber-Emmons - 2017 Member of Scientific Advisory Board
Adam M. Brufsky - 2023 Member of Medical Advisory Board
Alexander Kharazi - 2022 Member of Scientific Advisory Board
Massimo Cristofanilli - 2023 Member of Medical Advisory Board
Maria Trojanowska - 2017 Member of Scientific Advisory Board
Rebecca A. Taub 72 2019 Independent Director
Cara L. Haymaker - 2019 Member of Scientific Advisory Board
Jane A. Gross 67 2021 Independent Director
Suzanne Ostrand-Rosenberg - 2021 Member of Scientific Advisory Board
Sara A. Hurvitz - 2023 Member of Medical Advisory Board
Charles Sidman - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BCT Comments

Write your thoughts about Briacell Therapeutics Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email